RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSeoul National University Hospital

About this trial

To compare the effects of physiology- and imaging-guided PCI combined with optimal medical therapy (OMT) versus OMT alone on the recovery of left ventricular systolic function in patients with ischemic cardiomyopathy and multivessel coronary artery disease.

Eligibility criteria

Qualifiers

Subject must be ≥ 19 years

Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving invasive physiologic or imaging evaluation and PCI and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.

Subject with LV ejection fraction <40% from cardiac MRI

Subject with multivessel disease in major epicardial coronary artery disease or their major branches (vessel size of 2.5 mm or more than 2.5mm) considering coronary revascularization

Disqualifiers

Subjects with more than 50% transmural extent of infarction on GE-MRI in more than 25% of the dysfunctional myocardial segments

Subject with suspicious of other cardiomyopathy (dilated cardiomyopathy, hypertrophic cardiomyopathy etc.)

Subject with recent myocardial infarction within 4 weeks

Subject with recent fatal arrhythmia (VT or VF) within 4 weeks

Trial design

Treatments tested in this trial

  • Physiology-and imaging-guided PCI
  • Optimal medical treatment

Treatment groups

158 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Seoul National University Hospital

Lead sponsor

Seoul National University Bundang Hospital

Collaborator

Seoul National University Boramae Hospital

Collaborator